Eight Years of Growth Hormone Treatment in Children With Prader-Willi Syndrome

Autor: E. Van Pinxteren-Nagler, van Maria Leeuwen, Danny A. J. P. Haring, Joost Rotteveel, H. Van Wieringen, R. J. Odink, M. A. J. de Ridder, J. J. G. Hoorweg-Nijman, N. E. Bakker, A. A. E. M. Van Alfen, Gianni Bocca, G. C. B. (Karen) Bindels-de Heus, Rene C. F. M. Vreuls, E J Schroor, Dederieke A. M. Festen, Nitash Zwaveling-Soonawala, R. J. Kuppens, Euphemia C. A. M. Houdijk, L. Lunshof, Elbrich P. C. Siemensma, R. F. A. Tummers-de Lind van Wijngaarden, Anita C. S. Hokken-Koelega, Petr E. Jira, Wilma Oostdijk
Přispěvatelé: Pediatric surgery, ICaR - Circulation and metabolism, Faculteit Medische Wetenschappen/UMCG, Pediatrics, Psychiatry, Epidemiology, APH - Amsterdam Public Health, Obstetrics and Gynaecology, Other Research, Paediatric Endocrinology
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Zdroj: Journal of Clinical Endocrinology and Metabolism, 98(10), 4013-4022. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 98(10), 4013-4022. ENDOCRINE SOC
Bakker, N E, Kuppens, R J, Siemensma, E P C, van Wijngaarden, R F A T, Festen, D A M, van Bindels-de Heus, G C B, Bocca, G, Haring, D A J P, Hoorweg-Nijman, J J G, Houdijk, E C A M, Jira, P E, Lunshof, L, Odink, R J, Oostdijk, W, Rotteveel, J, Schroor, E J, Van Alfen, A A E M, van Leeuwen, M, van Pinxteren-Nagler, E, van Wieringen, H, Vreuls, R C F M, Zwaveling-Soonawala, N, de Ridder, M A J & Hokken-Koelega, A C S 2013, ' Eight Years of Growth Hormone Treatment in Children With Prader-Willi Syndrome: Maintaining the Positive Effects ', Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 10, pp. 4013-4022 . https://doi.org/10.1210/jc.2013-2012
Journal of Clinical Endocrinology and Metabolism, 98(10), 4013-4022. Endocrine Society
Journal of clinical endocrinology and metabolism, 98(10), 4013-4022. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 98(10), 4013-4022
ISSN: 0021-972X
DOI: 10.1210/jc.2013-2012
Popis: Background: The most important reason for treating children with Prader-Willi syndrome (PWS) with GH is to optimize their body composition.Objectives: The aim of this ongoing study was to determine whether long-term GH treatment can counteract the clinical course of increasing obesity in PWS by maintaining the improved body composition brought during early treatment.Setting: This was a multicenter prospective cohort study.Methods: We have been following 60 prepubertal children for 8 years of continuous GH treatment (1 mg/m(2)/d congruent to 0.035 mg/kg/d) and used the same dual-energy x-ray absorptiometry machine for annual measurements of lean body mass and percent fat.Results: After a significant increase during the first year of GH treatment (P Conclusion: This 8-year study demonstrates that GH treatment is a potent force for counteracting the clinical course of obesity in children with PWS.
Databáze: OpenAIRE